Re: IVA dumped - yet again
I don’t know how I missed this. It looks like the chairman of the board and CEO of NERV may be an advisor for the venture capital firm that’s been dumping shares of NERV? And was their CMO at one time? If I’m not misunderstanding what I’m reading or confusing two entities, I can see how the market would react poorly. If it’s the same venture capital company, the one thing that we can be sure of: insider information is not being leaked to even the closest business associates or large institutional investors. IVA dumped at worst time possible.
Executive Chairman & Chief Executive Officer
Dr. Remy Luthringer was named Executive Chairman of the Board on February 5, 2018 and has served as the Chief Executive Officer of Minerva Neurosciences, Inc. since November 2014. He has been involved in the development of more than 150 active molecules for clinical trials in the central nervous system. Dr. Luthringer is an Advisor at Medicxi Ventures, formerly Index Ventures, a venture capital firm comprising all of the life sciences portfolio companies, funds and team from Index Ventures. Previously, he served as Chief Medical Officer for Index Ventures, with a focus on investments in healthcare infrastructure. He was also the head of the FORENAP Institute for Research in Neurosciences and Neuropsychiatry in France. Dr. Luthringer has extensive experience in clinical psychiatric practice and holds a PhD in neurosciences and clinical pharmacology.